RTEZ — REST EZ Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1733861 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | 0 | 0 | 0 | 300 | 300 | 0 |
| Sep 2025 | 0 | 0 | 0 | 0 | 300 | 300 | 0 |
| Jun 2025 | 0 | 0 | 0 | 0 | 300 | 300 | 0 |
| Mar 2025 | 0 | 0 | 0 | 0 | 300 | 300 | 0 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,018
Investing CF
—
Financing CF
$3,318
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-286,101
Inventory
$0
Receivables
$0
ST Investments
—
EBIT TTM
$0
Pretax Income TTM
$0
Interest Exp TTM
$0
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2025 | 0 | -7,900 | -7,900 | 300 | 0 | — | -44,705 |
| Mar 2024 | 5,000 | -19,386 | -19,386 | 13,500 | 50,305 | — | -103,149 |
| Mar 2023 | 0 | -13,408 | -428,706 | 2,594 | 173,158 | — | -13,312 |
| Mar 2022 | 519,443 | 223,642 | 171,971 | 407,981 | 160,137 | — | -77,308 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.01T | $1133.00 | — |
| JNJ | JOHNSON & JOHNSON | $579.83B | $240.87 | — |
| ABBV | AbbVie Inc. | $402.35B | $227.73 | — |
| MRK | Merck & Co., Inc. | $294.03B | $119.05 | — |
| NVS | NOVARTIS AG | $292.07B | $153.07 | — |
Recent Insider Activity
No insider activity indexed for this ticker.